Type 1 diabetes mellitus with diabetic chronic kidney disease
ICD-10 E10.22 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with diabetic chronic kidney disease.
Type 1 diabetes mellitus (T1DM) is an autoimmune condition characterized by the destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Chronic kidney disease (CKD) is a common complication of diabetes, resulting from prolonged hyperglycemia and associated metabolic derangements. In patients with T1DM, the risk of developing diabetic CKD increases significantly, particularly when HbA1c levels are poorly controlled. The progression of CKD in diabetic patients is often insidious, with stages ranging from mild impairment to end-stage renal disease (ESRD). Management of T1DM with CKD requires a multidisciplinary approach, focusing on glycemic control, blood pressure management, and renal protective strategies. Insulin therapy remains the cornerstone of diabetes management, with adjustments made based on renal function. Regular monitoring of renal function, including serum creatinine and estimated glomerular filtration rate (eGFR), is essential to assess the progression of CKD and adjust treatment accordingly. Patients with E10.22 require careful management to prevent further complications, including cardiovascular disease and the need for renal replacement therapy.
Detailed records of HbA1c levels, insulin regimen, and diabetes management plans.
Patients presenting with uncontrolled diabetes and signs of renal impairment.
Endocrinologists must document the interplay between diabetes management and renal function closely.
Comprehensive assessment of renal function, including eGFR and proteinuria levels.
Patients with diabetes presenting for evaluation of CKD progression.
Nephrologists should document the impact of diabetes on renal health and any adjustments in diabetes medications.
Used for routine follow-up of a patient with T1DM and CKD.
Document the patient's diabetes management, renal function, and any changes in treatment.
Endocrinologists and nephrologists should ensure comprehensive documentation of both conditions.
HbA1c levels are crucial in managing Type 1 diabetes and assessing the risk of complications, including chronic kidney disease. Regular monitoring helps guide treatment adjustments to prevent further renal impairment.
